NMPA Approval

Drospirenone and Ethinylestradiol Tablets（Ⅱ）

Approval Number

H20140972

Registration Date

May 31, 2019

Previous Approval Numbers

H20140972

Drug Information

Generic Name

屈螺酮炔雌醇片(Ⅱ)

Brand Name

优思悦

Dosage Form

片剂

Strength

炔雌醇0.020mg和屈螺酮3.000mg

Drug Type

化学药品

Registration Date

May 31, 2019

Expiry Date

May 30, 2024

Company Address

875 Pacific Highway PYMBLE NSW 2073 Australia

Company Address

Dobereinerstraβe 20，99427 Weimar，Thuringia，Germany

Empowering clinical research with data-driven insights and AI-powered tools.

屈螺酮炔雌醇片(Ⅱ) - NMPA 批准文号 | MedPath